Immunology

Cost-effectiveness of allergen immunotherapy evaluated

(HealthDay)—Allergen immunotherapy (AIT) may be cost-effective for allergic rhinitis, and for venom allergy in high-risk subgroups, according to research published online July 18 in Allergy.

Immunology

Booster allergen immunotx cuts symptoms in allergic rhinitis

(HealthDay)—For patients with grass pollen-induced allergic rhinitis (AR), booster allergen immunotherapy (AIT) using tyrosine-absorbed grass pollen allergoids containing the adjuvant monophosphoryl lipid A (MPL) prevents ...

Health

Review: Little evidence on vitamin D-allergy association

(HealthDay)—Vitamin D supplementation seems not to prevent allergies in pregnant women, breastfeeding women, or infants, though there is very little evidence about the association between vitamin D and allergic diseases, ...

Diseases, Conditions, Syndromes

Open-label placebos seem to have positive clinical effect

(HealthDay)—Compared with no treatment, open-label placebos seem to have a positive clinical effect, according to a review published online April 27 in the Journal of Evidence-Based Medicine.

Immunology

AAAAI: obese girls appear to be more prone to atopic disease

(HealthDay)—Obese girls may face a significantly higher risk for developing allergies, according to research presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from March 3 to ...

page 8 from 14